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Identifying genomic variants is a fundamental first step toward the understanding of the role of inherited and acquired
variation in disease. The accelerating growth in the corpus of sequencing data that underpins such analysis is making
the data-download bottleneck more evident, placing substantial burdens on the research community to keep pace. As a
result, the search for alternative approaches to the traditional “download and analyze” paradigm on local computing resources has led to a rapidly growing demand for cloud-computing solutions for genomics analysis. Here, we introduce
the Genome Variant Investigation Platform (GenomeVIP), an open-source framework for performing genomics variant
discovery and annotation using cloud- or local high-performance computing infrastructure. GenomeVIP orchestrates
the analysis of whole-genome and exome sequence data using a set of robust and popular task-specific tools, including
VarScan, GATK, Pindel, BreakDancer, Strelka, and Genome STRiP, through a web interface. GenomeVIP has been used
for genomic analysis in large-data projects such as the TCGA PanCanAtlas and in other projects, such as the ICGC
Pilots, CPTAC, ICGC-TCGA DREAM Challenges, and the 1000 Genomes SV Project. Here, we demonstrate
GenomeVIP’s ability to provide high-confidence annotated somatic, germline, and de novo variants of potential biological
significance using publicly available data sets.
[Supplemental material is available for this article.]
Understanding the relationship between genetics and disease is a
central theme of biomedical research. Enabled by increasingly economical next-generation sequencing technologies, many projects
have sought to characterize variation within and across populations and disease cohorts. Among these are the 1000 Genomes
Project, The Cancer Genome Atlas (TCGA), UK10K, Pediatric
Cancer Genome Project (PCGP), and the International Cancer
Genome Consortium (ICGC), but numerous smaller-scale projects
are also under way. Advances in sequencing technologies and
further economies of scale are expected to increase the collective
corpus of sequence data dramatically, particularly as clinical diagnostic sequencing becomes more prevalent while expanding
across data types (methylation, mRNA, and miRNA) and especially
if widespread screening of asymptomatic individuals is implemented. For example, the Precision Medicine Initiative (PMI) envisions a longitudinal collection of genomic data from more than 1
million individuals (Collins and Varmus 2015).

The vast amounts of data produced by today’s sequencing
projects impose logistical challenges in downloading and storing
data prior to passing it through a pipeline of bioinformatics tools
running on local high-performance computing resources, i.e.,
the traditional “bringing data to the tools” paradigm of variant
analysis (Stein 2010). Cloud computing addresses both the computational and storage challenges associated with large data sets
by enabling users to launch on-demand virtualized instances of
computer systems with preinstalled tools and scripts that have
the ability to import source data from and export processed data
to cloud storage. Furthermore, the research community is transitioning to approaches that democratize access to genomic data
(Heath et al. 2014; Stein et al. 2015), resulting in the creation of resources such as the National Cancer Institute’s Genomic Data
Commons (GDC; http://gdc.cancer.gov), a comprehensive cancer
genomics repository. Cloud computing, where analysis is conducted by “bringing tools to the data,” is viewed as having an
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GenomeVIP cloud platform
important role in future bioinformatics analysis (Dudley et al.
2010), which is especially critical for independent scientists and
clinics that are unable to support a local high-performance computational infrastructure.
Here, we present the Genome Variant Investigation Platform
(GenomeVIP), a system for performing variant discovery, annotation, and interpretation using cloud resources. Its intuitive, lightweight web interface enables users to detect genomic variants
(single- and multinucleotide variants, short insertions and deletions [indels], complex indels, and structural alterations that include translocations, inversions, and tandem duplications) in
whole-genome or exome sequence alignment files (BAMs). We
highlight important functionalities of GenomeVIP and examine
its capabilities within the larger context of genomic data processing systems, demonstrating GenomeVIP as an engine for future
cancer and human genetic studies.

Results
GenomeVIP is an open-source, cloud-aware, multiuser platform
with a web interface for performing discovery, annotation, and interpretation of genomic variation. Its sophisticated design brings
powerful cloud resources to bear for task-specific bioinformatics
analyses without any special cloud expertise required by the investigator. Users can direct GenomeVIP to perform germline, somatic,
and de novo variant calling by selecting software from its palette of
widely used bioinformatics tools and can specify provided bestpractices discovery tool parameter sets or design a custom “execution profile” by adjusting online or uploading parameters through
the web interface. By providing both high- and low-level access to
tools and parameters, GenomeVIP provides flexibility for use by
computational biologist power users as well as by users having expert knowledge or particular research needs. Its design and operational aspects aim to promote the reproducibility, transparency,
and uniformity of the processing of genomic data. Although we focus on GenomeVIP’s cloud capability, it runs equivalently on local
high-performance computing clusters with local data with preinstalled versions of the named tools. The design and implementation of GenomeVIP and its usage for modern, high sample count
cancer genomics and human genetics research also serves as a
starting point for integration of additional tools and capabilities
and expansion to other cloud-computing platforms.

GenomeVIP architecture
The functionality of GenomeVIP is provided through coordination among three central components: the user’s web browser,
the GenomeVIP server, and a cloud-computing resource (Fig. 1).

Web browser
The GenomeVIP web browser interface (Fig. 1, top) furnishes user
controls for many tasks, including the following: loading sample
file information; selecting samples; choosing parameters and tools
for discovery, filtering, and annotation; selecting genomic regions;
and managing cloud computational and storage resources. The interface is implemented using a combination of HTML, JavaScript,
and cascading style sheets (CSS) and uses a jQuery JavaScript library to modify web page content and provide cross-browser compatibility. In addition, user-generated events and communications
between the browser and the GenomeVIP server are handled by
JSON-formatted AJAX requests, a standard jQuery feature.

Figure 1. GenomeVIP platform. GenomeVIP consists of three components (web browser, server host, cloud), coordinated by various scripting
languages (blue) and cloud toolkits (green). Interactive web pages, written
in HTML (with CSS elements) and JavaScript, provide front-end functionality. JQuery is a JavaScript library providing methods to modify web
page content with cross-browser compatibility. Server-side PHP modules
utilize StarCluster and S3 Tools cloud toolkits to access EC2 Compute
(gray) and storage resources (yellow) in the cloud. GenomeVIP creates
within EC2 a virtual cluster, based on a machine image with preinstalled
variant detection tools and supporting software (collectively, “Genomics
Tools”) (red), that can access sequence data on S3 and EBS (Elastic Block
Storage) resources (yellow). Secure channels using HTTPS and secure shell
(SSH) protocols allow communication between various components.
Resulting variant call files stored in S3 are accessible via the GenomeVIP interface or the Amazon S3 Console.

Server host
The GenomeVIP server (Fig. 1, middle) runs a secure Apache
HTTPS web server that may be installed and run locally as a real
or virtual machine (VM) or that may be instantiated as a VM on
Amazon Web Services (AWS). Server-side scripts written in PHP
handle user selections and generate content for client-side interpretation and storage within the user’s web browser (Fig. 1, top).
To configure a computation to run on the AWS cloud, users
provide their previously established AWS login credentials, specify
genomic samples, and select one of the predefined analysis pipelines and parameter sets, which may be further customized.
Users then specify storage and computing resources required,
i.e., a VM instance type (giving a certain number of processors
and memory) and the number of nodes or virtual cluster size.
The server automatically builds the necessary configuration files
for the StarCluster (http://star.mit.edu/cluster) and S3 Tools (http
://s3tools.org) cloud toolkits to manage AWS computing and storage resources, respectively. After users submit a computation, the
server performs key tasks: instantiating cloud computing resources; generating a master script that creates template-subordinate
work scripts to perform the variant discovery, post-discovery processing, and storing of results in parallel fashion across genomic
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regions and tools; and transmitting the
work scripts to the targeted computing
host for execution.

The cloud
Cloud resources (Fig. 1, bottom) consist
of cloud computational and storage components as specified by users on the
GenomeVIP server. Here, Amazon’s
Elastic Compute Cloud (EC2) computational infrastructure hosts a virtual cluster instantiated by GenomeVIP from a
prebuilt run-time virtual machine (VM)
image containing well-established variant discovery tools—VarScan (Koboldt
et al. 2009, 2012, 2013), Pindel (Ye et
al. 2009), GATK (McKenna et al. 2010;
DePristo et al. 2011; Van der Auwera
et al. 2013), BreakDancer (Chen et al.
2009; Fan et al. 2014), Genome STRiP
(Handsaker et al. 2011), and Strelka
(Saunders et al. 2012)—with supporting
genomics software and the S3 Tools
cloud toolkit for interacting with the
AWS Simple Storage Service (S3) cloud
(Sarna 2011). GenomeVIP automatically
mounts volumes from Amazon’s Elastic
Block Store (EBS) resource containing
any user-specified BAM alignment and
reference genome files to the cluster.
Examples of mountable EBS volumes
include encrypted volumes created by
users, data providers, or collaborators under the given AWS account and any pub- Figure 2. GenomeVIP workflows. Three variant-discovery pipelines (germline, somatic, and de novo)
with predicted variant types, including single-nucleotide variants (SNVs), insertions and deletions
lic, unencrypted volumes. (GenomeVIP
(indels), structural variants (SVs); selected filtering features; and post-discovery annotation options prodoes not address access control lists
vided by third-party software packages having knowledge of catalogs of genetic variation.
[ACLs] for data, but we note their use at
the AWS account level may help to enforce regulatory data access and usage policies.) Files located in
structural variants (SVs) that include inversions, copy-number varS3 are another source of input. When executed, the master script
iation, tandem duplications, and inter- and intra-chromosomal
automatically submits work scripts as batch jobs to the local job retranslocations. Results are reported in VCF format.
source manager (e.g., SGE on AWS and LSF on local clusters) for
handling job concurrency and dependencies. As work units are
completed, GenomeVIP transmits raw and final results to the specVariant filtering
ified storage location (i.e., S3 storage on AWS or a results directory
GenomeVIP provides several user-adjustable filtering modules,
on local clusters).
which encapsulate various tool-specific methods or rule-based

GenomeVIP components
The functional units within GenomeVIP collectively implement
variant analysis of genomic data (Fig. 2). They encompass sets of
public tools most trusted and most often relied upon by investigators for their respective tasks.

Variant detection
GenomeVIP deploys pipelines for germline, somatic, and de novo
variant discovery with helper modules for performing filtering and
annotation. The platform incorporates well-established, widely
used tools, i.e., VarScan, GATK, Strelka, BreakDancer, Pindel,
MuTect2, and Genome STRiP, for the detection of single-nucleotide variants (SNVs), small insertions and deletions (indels), and
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heuristics, to refine raw variant calls. Such filters include
VarScan’s own germline and somatic high-confidence filter as
well as a new de novo/family trio filter we developed that considers
the maximum total number of supporting reads in the parents.
The BreakDancer filter we developed removes somatic calls having
read support in the normal or de novo calls having read support in
either parent. Pindel analysis incorporates a unified germline,
somatic, and de novo filter we developed that considers read coverage, variant allele frequency, strandedness, read support, and
homopolymer repeat length. Further details on these three new filters are provided in Methods. GenomeVIP also provides dbSNP
(NCBI v.142, GRChr37 and GRCh38) and a false-positive filter as
high-level filters. These methods are based in part on published
(Xu et al. 2014) best practices for these tools, our results in
the ICGC-TCGA DREAM Somatic Mutation Calling challenge

Downloaded from genome.cshlp.org on August 19, 2017 - Published by Cold Spring Harbor Laboratory Press

GenomeVIP cloud platform
(http://www.synapse.org/#!Synapse:syn312572/wiki/58893), and
our germline and somatic calling in the ICGC-TCGA Pan-Cancer
Analysis of Whole Genomes Somatic Mutation Calling
Challenge (Pilot-63) Validation project (http://www.synapse.org/
#!Synapse:syn2875157). Finally, GenomeVIP can accept user-designated VCF files for filtering against a pan-normal data set.

Variant annotation
GenomeVIP furnishes several annotation methods: dbSNP, which
provides various information on all known short sequence
variation; the Ensembl Variant Effect Predictor system (VEP)
(McLaren et al. 2010), including its interfaces to individual tools
like SIFT (Ng and Henikoff 2003) and PolyPhen (Adzhubei et al.
2013), which provides information on the impact of variants on,
e.g., genes, transcripts, protein sequences, and regulatory regions;
and ClinVar (Landrum et al. 2016), which provides interpretations
of the clinical significance of variants.

GenomeVIP dynamic interface
GenomeVIP session configuration spans the spectrum of running
“out of the box” almost wholly on defaults to accepting customized user instructions for practically every step. Following modern
user application programming practices, the graphical interface is
highly menu-driven. A navigational menu summarizes the core
steps of the configuration and execution process (Fig. 3, top).
Activation of any of these items in the interface (via user mouse
click) updates an adjacent display panel to show the corresponding
options (Fig. 3A–F), each of which is described in more detail below.

Accounts
First, users provide their login credentials for Amazon Web Services
(AWS) or a local high-performance compute cluster, depending on
where the input data are located and thus where the computations
are to be run (Fig. 3A). GenomeVIP employs semipersistent “sessions” to facilitate reuse of instantiated AWS computing resources.
For local clusters, users may submit jobs to specific hosts and
queues.

Select genomes
Next, users specify genomic data sources (Fig. 3B). GenomeVIP recognizes sequence alignment files in BAM format and reference genomes in FASTA or compressed FASTA format. On AWS, users may
provide cloud storage volumes with prepared file lists or opt to use
one of the prepared 1000 Genomes Project donor sample sets (i.e.,
pilot phase; phase 1 low-coverage or exome; or phase 3 low-coverage, high-coverage, or exome). On local clusters, GenomeVIP can
obtain remote directory file listings directly (via SSH secure shell).
The server parses the data sources and presents the alignment and
reference files for selection. GenomeVIP notes any missing index
or dictionary files and generates directives to create them at run
time as necessary. This framework is sufficiently general to handle
nonhuman genomes wherever supported by the variant detection
tools.

Execution profile
In this series of tabbed panels (Fig. 3C,D), users design an “execution profile” consisting of their choice of variant detection, filtering, and annotation tools. The “Quick Setup” tab (Fig. 3C)
provides access to several built-in execution profiles, based on

best practices and our own experience that can afford high-quality
calls. A Run Mode field sets the study type (i.e., germline, somatic,
or de novo) and filtering and annotation options, and a Parameters
field accounts for the sequence data type (i.e., whole-genome or
exome), depth of coverage (i.e., low or targeted), and palette of applied filters. Users may also upload execution profiles through
their web browser, enabling them to readily reuse settings from prior computations to ensure consistency across multiple runs. Users
can select from predefined chromosome sets or specify a custom
list of chromosomes and/or regions by entering details directly
or by uploading a list file of regions. Options within the individual
tools’ tabs or the Post-discovery Analysis tab allow customization
of the current profile (Fig. 3D). For example, the user can include
or exclude particular discovery tools from the analysis or modify
the more commonly altered discovery parameters. GenomeVIP
also utilizes collapsible panels (e.g., Fig. 3D, “Options”) to provide
users with access to other command line parameters offered by particular tools. Modules for performing false-positives filtering, including filtering by a user-supplied panel-of-normals VCF file,
and annotation by dbSNP, VEP (McLaren et al. 2010), and
ClinVar (Landrum et al. 2016) are available.

Submit
In the final steps of preparing a computation, users select the computing resource and finalize the execution profile (Fig. 3E). On
AWS, users select whether to launch a new virtual computing cluster or reuse an existing cluster and specify the top-level destination
(S3 “bucket”) for storing results and supporting output (see below).
On local clusters, users designate the working directory in which
the computations are executed. Buttons to preview, validate (or error-check), or download the current execution profile are available.
These functions also are available to users throughout the configuration process to assist them in preparing their job so that it executes as intended. Submitting the computation causes a final
validation check to be performed and, if successful, a summary
of the submission is displayed with a jobID for identifying the
computation.

Results
GenomeVIP places various outputs in the location specified by the
user during the Submit step. As shown in Figure 3F, the main results are placed in a “Results” folder, and the raw outputs and intermediate results are stored in folders corresponding to
individual variant tools. As the time needed to complete an analysis is expected to vary significantly depending on the type of analysis and the complexity of the sample, GenomeVIP uses a “status”
subdirectory with sentinel files indicating which discrete jobs in
the workflow are unfinished. The main location contains a copy
of workflow script (file: ∗ .sh) and the execution profile (file: ∗ .ep)
serving as a record of the computation. Execution profiles may
be uploaded to GenomeVIP in future computations to ensure uniformity in processing across multiple runs. Users may obtain results and job status information for AWS computations either by
providing the S3 storage location and jobID of the computation
to a running GenomeVIP server, or by logging into the AWS
Console (“dashboard”) to navigating to the S3 storage service.
Either of these methods allows users to download files through
the browser using secure HTTPS protocols. Access to results and
job status for computations run on local clusters can be obtained
in an analogous manner to AWS by providing the working
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Figure 3. GenomeVIP screenshots. (A) Accounts. Presentation of the user’s valid Amazon Web Services causes GenomeVIP to generate a semipersistent
sessionID used to store or recall previous cloud resource configurations. (B) Select Genomes. A user-uploaded file listing sequence alignment, reference, and
index files is parsed and displayed for item selection. (C) Quick Setup tab configuration for loading a built-in execution profile with predefined tools and
parameters (Step 1, option 1); a profile may alternatively be uploaded via the interface (Step 1, option 2). Predefined genomic regions may be selected or
uploaded via the interface (Step 2). Clicking the Apply Profile button (Step 3) configures tools listed under the other tabs (gray) with the current predefined
profile and regions, which may be subsequently modified manually under the other tabs. (D) Post-discovery Analysis. Selection of filters and annotation as
part of the execution profile, showing the expanded false-positives filter panel (gray) for customization. (E) Submit. Resource management options are
provided to create new or reuse existing computing instances and cloud storage location. Buttons to preview, download, or error-check the current execution profile, or to submit it as a computation, are available. (F) Results. An Amazon cloud storage file listing showing folders for tools’ outputs, job status,
and results. Files .sh and .ep represent the master script describing the computation’s workflow and the execution profile, respectively.

directory of the computation to a running GenomeVIP server or
via command-line login to the user’s cluster account.

Options
Features in this panel (not shown) allow users to manage several advanced features of Amazon cloud operations, such as deac-
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tivating the use of encrypted streams for data in transit to and
from AWS S3 cloud storage and terminating instantiated AWS
clusters. Users may launch an updated GenomeVIP runtime
machine image instead of the server’s built-in default by providing the corresponding Amazon machine image (AMI) identification tag.
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Discussion
Use with big data
In addition to numerous smaller-scale projects, GenomeVIP has
been used in several major projects, two of which are listed in
Table 1: the International Cancer Genome Consortium (ICGC)
Somatic Pilot and the TCGA PanCan Germline projects. In the
ICGC project, GenomeVIP invoked the native somatic calling capability of VarScan and Strelka and directed Pindel to generate calls
for each matched pair in cohort mode. Generating these calls consumed more than 9000 CPU-hours, with the pairs requiring on average 11.7, 40.8, and 135 CPU-hours for VarScan, Strelka, and
Pindel, respectively. In the TCGA PanCan Atlas germline analysis
project, more than 8000 samples across 22 tumor types were processed individually with VarScan, GATK, and Pindel using our
in-house pipeline. Comparison of these local-based calls to those
generated more recently on cloud resources have produced excellent recall rates for insertions and deletions (∼96%) and for single-nucleotide variants (>99%), the difference being largely
attributable to the use of more recent tool versions. The tool-specific CPU usage here was 8.2, 5.4, and 10.2 CPU-hours for VarScan,
GATK, and Pindel, respectively.

Comparison to existing cloud pipelines
Genomic sequencing has long been supported by automated processing of raw data (Wendl et al. 1998); as a result, a variety of systems, many of which are deployable on cloud computing
resources, have become available with varying levels of capability,
user convenience, and sophistication. Early entries only targeted
specific parts within the larger process, e.g., applying cloud technologies to the genome alignment process (Langmead et al.
2009; Schatz 2009; Wall et al. 2010), but recent work has progressed toward solutions that are more complete. The positioning
of GenomeVIP within this milieu has been guided by its underlying design goal of furnishing an intuitive, graphics-based system to
the nonspecialist biomedical investigator for harnessing well-established, task-specific, external tools to analyze WGS/WES data
for somatic, germline, and de novo variants using on-demand
cloud resources. A comparison of features across a selection of
comparable systems is presented in Table 2.

Intuitive, web-based control
Special bioinformatics skills related to transferring large files, database creation, programming, or algorithms are required to use systems such as Atlas2 Genboree (Evani et al. 2012), the COSMOS
library (Gafni et al. 2014), or the CloudBioLinux tool set
(Krampis et al. 2012), and familiarity with Unix/Linux command-line functionality is needed to easily run tools like TREVA
(Li et al. 2014), TOGGLE (Monat et al. 2015), HugeSeq (Lam

Table 1.

et al. 2012), GotCloud (Jun et al. 2015), or Churchill (Kelly et al.
2015). Many systems also have more subtle aspects of designing
a calculation, for example, manually discretizing genomic regions
for parallelization (Afgan et al. 2010). GenomeVIP enables complete specification of job execution entirely by web-interface
menu prompting, making it easier for users without considerable
bioinformatics experience to undertake genomic analyses.

Vetted tools
Some approaches rely on native methods for processing, e.g., AtlasSNP2 and Atlas-Indel2 in the Atlas2 Cloud and Mercury (Reid et al.
2014) systems, and almost all lack capability for managing the full
array of biomedically relevant variant types. For example, most
systems (Evani et al. 2012; Li et al. 2014; Jun et al. 2015; Kelly
et al. 2015) cannot handle SVs, and none treat any type of complex
indels. GenomeVIP follows a UNIX-like philosophy of recruiting
only highly vetted, task-specific external tools and porting them
for cloud compatibility. GenomeVIP runs each tool with fully
specified parameter lists to guard against inadvertent changes of
defaults. It also supports the reuse of custom execution profiles
for repeating an analysis, which may be helpful for performing
longitudinal studies on the same patient or for simply dividing a
large data set into smaller computational sets.

Data privacy protection
The GenomeVIP server uses secure HTTPS by default, with encryption specifications consistent with HIPAA standards, to communicate with the user’s web browser. The StarCluster toolkit uses
secure shell (SSH) encrypted protocol for communicating with
and transferring files to/from Amazon. The S3 Tools toolkit is configured by GenomeVIP by default to use HTTPS when transmitting
data between computing resources and S3 cloud storage and to request server-side encryption (AES-256 protocol) be applied to new
data stored at rest in S3. When used with a local cluster,
GenomeVIP uses SSH when accessing the remote file system and
when transferring files to/from the cluster.

Example comparison
We compared GenomeVIP directly to another cloud-based analysis system, namely GotCloud (Jun et al. 2015). As the latter does
not readily handle somatic or trio analysis, we have limited the
comparison to germline variants. In particular, we used
GotCloud to repeat the germline analysis of the nine cases from
the 1000 Genomes Project discussed above. Downstream analysis
revealed that dbSNP concordances of GotCloud-generated calls
were 99.0%–99.7% for SNVs and 88.5%–93.0% for indels, both
of whose ranges are comparable to the results from GenomeVIP
(Fig. 4F).

Examples of large-scale projects utilizing GenomeVIP
Computational resources (CPU-h)

Project
ICGC Somatic Pilot-50
TCGA Germline
a

Variants (millions)

Samples

VarScan2

GATK

Strelka

Pindel

SNVs

Indels

SVs

50 WGS pairs (tumor/normal)
8695 WXS samples

583
71,081

N/A
47,305

2041
N/A

6770
88,333

44 × 105 a
4.3 × 109 b

0.94 × 105 a
0.9 × 109 b

1.0 × 105 a
N/A

Unique, filtered.
Nonunique, raw.

b
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Table 2. Brief comparison of variant discovery frameworks
Pipeline

Software

Version

GenomeVIP
TREVA
HugeSeq
Atlas2 Genboree
Mercury
Churchill
GotCloud
TOGGLE

v1.2
v.1
v2.0
website, accessed
2016-01
v3.2.1
v1.8
v1.14.4,
ami-6ae65e02
v0.2 (2015-10-08)

Variants

Som Germ De novo SNV Indel SV CNV Anno
✓
✓

✓
✓
✓
✓

✓

✓
✓
✓
✓

✓
✓
✓
✓

✓

✓
✓
✓

✓
✓
✓

✓
✓
✓

✓
✓
✓

✓

✓

✓

✓

✓

✓
✓
✓

✓
✓
✓
✓

Web GUI

Cloud APIAware

✓

✓

Machine
image
available

Userinstalled
required

✓(AWS)
✓

optional

✓
✓(DNAnexus) ✓(DNAnexus)
✓(AWS)
✓

✓
optional
✓
optional

Software packages are compared according to the following: the types of pipelines (Som, somatic; Germ, germline; De novo, de novo) and callable
variants (SNV, single-nucleotide polymorphism; Indel, short insertions and deletions; SV, structural variants; CNV, copy number variation) available;
built-in annotation (Anno) options; presence of native or supported web browser graphical user interface (Web GUI) and built-in cloud resource management tools (Cloud API-Aware); availability of ready-to-run, pre-built machine images; and requirement for manual installation of the software
package itself and/or supporting genomics software.

Methods
GenomeVIP genomic applications
GenomeVIP includes tools to perform germline, somatic, and de
novo variant discovery and annotation. We illustrate these capabilities with three examples: (1) germline variant discovery from
exome samples from a large cohort; (2) somatic variant detection
on a synthetic matched tumor/normal sample pair; and (3) de
novo analysis of a well-studied family trio from the 1000
Genomes Project. Parameters used are available in Supplemental
Information. In each case, local and cloud deployments of
GenomeVIP produced identical raw calls. We also confirmed the
parallelizability of genomic regions by performing cloud computations over entire chromosomes and local computations by processing 10-Mb windows spanning the entire genome. Performance and
compute statistics are reported in Figure 4D and Supplemental
Information.

Germline
We selected nine unrelated donors from the 1000 Genomes
Project (Abecasis et al. 2010), three each from three populations
(CHB, FIN, YRI) and directed GenomeVIP to launch VarScan and
Pindel variant callers to perform SNV and indel discovery on
Chromosome 20 using discovery parameters used in a previous
germline analysis (Kanchi et al. 2014). Raw calling performance,
as measured by dbSNP concordance, revealed SNV concordances
ranging from 97.0% to 98.1% and indel concordances ranging
from 92.2% to 96.2%. To validate the germline variants, we then
conducted a downstream principal component analysis of the
SNVs using PLINK (Chang et al. 2015) and found that analysis
faithfully recapitulated the population structures of these three
ethnic groups (Fig. 4A).

Somatic
We called somatic mutations in the matched tumor/normal synthetic DREAM-3 samples, the most complex of the open-access
data sets from the ICGC-TCGA DREAM Somatic Mutation
Calling (SMC) Challenge (Ewing et al. 2015). We directed
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GenomeVIP to generate raw calls using VarScan and Strelka with
limited filtering to enable downstream exploration of the effect
of selected false-positive filtering parameters, namely, the number
of supporting reads and read mapping qualities (Methods).
Calculations of true-positive (TP) and false-positive (FP) rates,
based on unmasked regions of a known synthetically generated tumor’s “truth” set (Ewing et al. 2015), for multiple combinations of
parameter sets for the individual, intersected, and combined filtered call sets, is plotted on receiver operating characteristic
(ROC) curves (Fig. 4B). Comparison of unfiltered, novel calls reveals comparable TP but significantly different FP rates for
VarScan and Strelka callers. Although Strelka’s TP rates (ranging
from 0.784 to 0.789) and FP rates (ranging from 0.011 to 0.016)
did not appreciably change across the false-positives parameter
landscape investigated, increasing the number of required variant-supporting reads (VSR) to four for filtering VarScan calls dramatically decreased FP rates while also modestly decreasing TP
rates. This contrast in behavior is a result of VarScan having produced manifold more putative calls than Strelka in the “unmasked” genomic regions targeted by the evaluator script.
Finally, the intersections of calls from the two callers were found
to be largely invariant (TP, ∼62.7%; FP ∼0.94%), supporting the
view that combining calls from multiple callers may be an effective
strategy to identify a core set of high-quality calls while mitigating
against a significant portion of false positives (Cantarel et al.
2014).
This exercise also serves as a case study, showing the creation
of expert knowledge and experience that investigators may wish to
capture for subsequent analyses, such as maximizing sensitivity
for discovery or specificity for diagnostic purposes. Users can
then provide these optimal parameter values as previously described to perform a complete run.
A similar approach was used to process WGS tumor/normal
matched pairs from more than 10 different cancer types for the
ICGC Pan-Cancer project. In the initial “Pilot 50” project,
GenomeVIP produced 4.4 million SNV, 94,000 indel, and
100,000 SV filtered calls (Table 1) that we submitted for evaluation
for selection for validation experiments. The comparison between
GenomeVIP’s predictions and those from eight other standard
pipelines showed that GenomeVIP produces results highly concordant with noncloud pipelines (Fig. 4C), suggesting high-quality,
reproducible analysis.
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variant read-support filter for the parental genomes showed that exclusion of
variant support in the parents (PVSR =
0) yielded the smallest GenomeVIP call
set (N = 2431) with a recall rate of 95.0%
(Fig. 4E, blue curve); in this set, 41 calls
were validated experimentally as false
positives. Increasing PVSR resulted in
larger GenomeVIP variant call sets by at
least 13% (Fig. 4E, red curve), while improving recall rates only marginally. For
example, at PVSR = 2, at which the recall
rate has plateaued, GenomeVIP made
3302 final calls, of which 42 validated
as false positives. In this example, the
highest balanced accuracy is likely to be
obtained for values of PVSR at or near
zero.

Software availability
The GenomeVIP source code and associated scripts are freely available for academic use and are available through
GitHub
(https://github.com/ding-lab/
GenomeVIP/) and as Supplemental
Code. Users having Amazon Web Services (AWS) login credentials can launch a
GenomeVIP server on the AWS cloud
by instantiating server images located in
the AWS public repository. GenomeVIP
executes computations using a public
run-time AWS image providing a nearly
complete set of the required genomics
software. Software packages on these images carry their own licensing and usage
terms. For example, GenomeVIP requires
users to provide the location of their own
licensed copy of GATK (version 3.5 and
higher supported). Installation of
GenomeVIP on a local web server allows
users to design and execute computaFigure 4. Applications of GenomeVIP. (A) Principal component analysis of germline SNV and indel pretions on a local high-performance comdictions for nonrelated 1000 Genomes Project Phase 1 samples from three populations: (red) CHB;
pute cluster using local data or on
(green) FIN; (blue) YRI. (B) True-positive (TP) and false-positive (FP) rates for somatic SNV calls novel
Amazon’s cloud using data stored at
to dbSNP. Performance of VarScan and Strelka callers individually (red, blue) and in combination (green,
AWS; furthermore, GenomeVIP’s interpurple) are evaluated before and after exploratory false-positives filtering using multiple parameter combinations, in which VSR is the minimum number of variant-supporting reads. (C ) GenomeVIP perfornal configuration files may be edited
mance on ICGC Pan-Cancer Pilot-50 somatic mutation calling for one matched sample pair, in which
manually to point to local versions of
the colors correspond to the number of pipelines predicting the same variant. (D) Performance statistics.
the tools on which GenomeVIP depends.
(E) De novo recall performance (blue), as compared to published experimental validation results, and filGenomeVIP orchestrates many tools that
tered call set size (red) for SNV calling in NA12878 as a function of PVSR, the number of variant-supportare all upgraded independently, and
ing reads in parental genomes NA12891 and NA12892. (F) dbSNP concordances of germline SNVs and
indels, as called by GenomeVIP (darker shading) and GotCloud (lighter shading), for the samples dethese updates will be passed through to
scribed in A.
GenomeVIP users in the following
ways: Tool updates not requiring user interface modification will be distributed
in updated runtime images, but those reDe novo SNV mutations in family trios
quiring such modification will require an
We analyzed the NA12891-NA12892-NA12878 family trio samupdated server image. Tool versions will accumulate rather than be
ples for de novo single-nucleotide variants using VarScan and assoreplaced to preserve backward compatibility. Database updates will
ciated filtering modules provided by GenomeVIP and compared
be managed similarly, although the user can alternatively specify
the results to experimentally validated germline and somatic de
the location of public or custom annotation VCFs that Genomenovo variants (Conrad et al. 2011). GenomeVIP attained 97.8% reVIP can retrieve via FTP/HTTP or from Amazon cloud storage. Doccall (979 of 1001 experimentally validated sites) after predicted
umentation, support, and further information is available through
false positives were removed. The additional effect of applying a
GitHub and the GenomeVIP home page at our Turnkey Variant
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Analysis Project website (http://tvap.genome.wustl.edu/tools/
genomevip/).
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